These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 10520863
1. Clinical significance of TT virus infection in patients with chronic hepatitis C. Zein NN, Arslan M, Li H, Charlton MR, Gross JB, Poterucha JJ, Therneau TM, Kolbert CP, Persing DH. Am J Gastroenterol; 1999 Oct; 94(10):3020-7. PubMed ID: 10520863 [Abstract] [Full Text] [Related]
2. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease. Tokita H, Murai S, Kamitsukasa H, Yagura M, Harada H, Takahashi M, Okamoto H. J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995 [Abstract] [Full Text] [Related]
3. A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma. The Brescia HCC Study. Tagger A, Donato F, Ribero ML, Binelli G, Gelatti U, Portera G, Albertini A, Fasola M, Chiesa R, Nardi G. Hepatology; 1999 Jul; 30(1):294-9. PubMed ID: 10385670 [Abstract] [Full Text] [Related]
4. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon. Nishizawa Y, Tanaka E, Orii K, Rokuhara A, Ichijo T, Yoshizawa K, Kiyosawa K. J Gastroenterol Hepatol; 2000 Nov; 15(11):1292-7. PubMed ID: 11129224 [Abstract] [Full Text] [Related]
6. [The prevalence of TTV infection in non-A to G chronic liver disease, especially non-A to G hepatocellular carcinoma, and the clinical significance of TTV infection]. Shibayama T, Igari T, Tsuda F. Nihon Rinsho; 1999 Jun; 57(6):1356-61. PubMed ID: 10390998 [Abstract] [Full Text] [Related]
7. TT virus infection during chronic hepatitis C. Trimoulet P, de Lédinghen V, Ekouevi D, Bernard PH, Merel P, Chêne G, Couzigou P, Fleury H. Am J Gastroenterol; 2000 Jul; 95(7):1765-9. PubMed ID: 10925982 [Abstract] [Full Text] [Related]
8. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis. Moriyama M, Mikuni M, Matsumura H, Nakamura H, Oshiro S, Aoki H, Shimizu T, Yamagami H, Shioda A, Kaneko M, Tanaka N, Arakawa Y. Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043 [Abstract] [Full Text] [Related]
9. Clinical implications of TT virus superinfection in patients with chronic hepatitis C. Watanabe H, Saito T, Kawamata O, Shao L, Aoki M, Terui Y, Mitsuhashi H, Matsuo T, Takeda Y, Saito K, Togashi H, Shinzawa H, Takahashi T. Am J Gastroenterol; 2000 Jul; 95(7):1776-80. PubMed ID: 10925984 [Abstract] [Full Text] [Related]
10. Hepatocellular carcinomas infected with the novel TT DNA virus lack viral integration. Yamamoto T, Kajino K, Ogawa M, Gotoh I, Matsuoka S, Suzuki K, Moriyama M, Okubo H, Kudo M, Arakawa Y, Hino O. Biochem Biophys Res Commun; 1998 Oct 09; 251(1):339-43. PubMed ID: 9790957 [Abstract] [Full Text] [Related]
11. Hepatitis C virus genotypes and the development of hepatocellular carcinoma. Stankovic-Djordjevic D, Djordjevic N, Tasic G, Dinic M, Karanikolic A, Pesic M. J Dig Dis; 2007 Feb 09; 8(1):42-7. PubMed ID: 17261134 [Abstract] [Full Text] [Related]
12. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma. Nakagawa N, Ikoma J, Ishihara T, Yasui N, Fujita N, Iwasa M, Kaito M, Watanabe S, Adachi Y. Cancer; 1999 Oct 15; 86(8):1437-40. PubMed ID: 10526270 [Abstract] [Full Text] [Related]
14. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease. Pramoolsinsap C, Poovorawan Y, Sura T, Theamboonlers A, Busagorn N, Kurathong S. Southeast Asian J Trop Med Public Health; 1998 Sep 15; 29(3):480-90. PubMed ID: 10437943 [Abstract] [Full Text] [Related]
15. Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt. Gad A, Tanaka E, Orii K, Kafumi T, Serwah AE, El-Sherif A, Nooman Z, Kiyosawa K. J Med Virol; 2000 Feb 15; 60(2):177-81. PubMed ID: 10596018 [Abstract] [Full Text] [Related]
16. [Relationship between TT virus infection and hepatocellular carcinoma]. Zhu F, Qian JM, Yang XO, Sun G, Lu CM. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec 15; 23(6):627-30. PubMed ID: 12901112 [Abstract] [Full Text] [Related]
17. Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States. Reid AE, Koziel MJ, Aiza I, Jeffers L, Reddy R, Schiff E, Lau JY, Dienstag JL, Liang TJ. Am J Gastroenterol; 1999 Jun 15; 94(6):1619-26. PubMed ID: 10364034 [Abstract] [Full Text] [Related]
18. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. Zein NN, Poterucha JJ, Gross JB, Wiesner RH, Therneau TM, Gossard AA, Wendt NK, Mitchell PS, Germer JJ, Persing DH. Am J Gastroenterol; 1996 Dec 15; 91(12):2560-2. PubMed ID: 8946986 [Abstract] [Full Text] [Related]
19. Relationships between TT virus infection and hepatitis C virus response to interferon therapy in doubly infected patients. Maggi F, Fornai C, Tempestini E, Andreoli E, Lanini L, Vatteroni ML, Pistello M, Marchi S, Antonelli G, Bendinelli M. J Biol Regul Homeost Agents; 2003 Dec 15; 17(2):176-82. PubMed ID: 14518719 [Abstract] [Full Text] [Related]
20. [Viral co-infections in hepatitis C: HBV, HBV-C/HGV and TTV studies]. Pár A, Takács M, Brojnás J, Berencsi G, Paál M, Horányi M, Miseta A, Hegedüs G, Mózsik G, Hunyady B. Orv Hetil; 2004 May 09; 145(19):987-92. PubMed ID: 15181733 [Abstract] [Full Text] [Related] Page: [Next] [New Search]